BACKGROUND: Several magnetic resonance imaging (MRI) parameters are known to be associated with short-term outcome in multiple sclerosis (MS) patients. MS-related disability typically progresses over decades, stressing the need for longer follow-up studies. Until now, these studies are relatively sparse and, therefore, the predictive value of MRI parameters for clinical disability remains largely unknown. OBJECTIVE: To assess the predictive value of brain MRI parameters, which are obtained during the first 3.3 years of the study for overall disease severity as measured by the MS Severity Score (MSSS) after 12.2 years follow-up. METHODS: Forty-six MS patients were included in the study. MRI parameters included both lesion loads and atrophy m...
Using serial magnetic resonance imaging (MRI), we investigated the relationship between diffuse cere...
OBJECTIVE: The objective of this paper is to identify clinical or magnetic resonance imaging (MR...
INTRODUCTION: T2-weighted and gadolinium enhanced T1-weighted MRI scans measure plaque burden and br...
Contains fulltext : 80250.pdf (publisher's version ) (Closed access)BACKGROUND: Se...
Objective: Magnetic resonance imaging (MRI) and clinical parameters are associated with disease prog...
Magnetic resonance imaging (MRI) is frequently used to monitor new treatments in multiple sclerosis ...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
Background and purposeBrain MRI-derived lesions and atrophy are related to multiple sclerosis (MS) d...
Magnetic resonance (MR) imaging is very sensitive in showing disseminated MS lesions. Subclinical MR...
BACKGROUND: Neuroaxonal loss is a pathological substrate of disability in progressive multiple scler...
BACKGROUND: Conventional MRI lesion measures modestly predict long term disability in some clinicall...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
In this study, the course of 60 consecutive multiple sclerosis patients (relapsing-remitting (RR), r...
The association of pathology and neurological deficit with quality of life (QoL) in multiple scleros...
Using serial magnetic resonance imaging (MRI), we investigated the relationship between diffuse cere...
OBJECTIVE: The objective of this paper is to identify clinical or magnetic resonance imaging (MR...
INTRODUCTION: T2-weighted and gadolinium enhanced T1-weighted MRI scans measure plaque burden and br...
Contains fulltext : 80250.pdf (publisher's version ) (Closed access)BACKGROUND: Se...
Objective: Magnetic resonance imaging (MRI) and clinical parameters are associated with disease prog...
Magnetic resonance imaging (MRI) is frequently used to monitor new treatments in multiple sclerosis ...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
Background and purposeBrain MRI-derived lesions and atrophy are related to multiple sclerosis (MS) d...
Magnetic resonance (MR) imaging is very sensitive in showing disseminated MS lesions. Subclinical MR...
BACKGROUND: Neuroaxonal loss is a pathological substrate of disability in progressive multiple scler...
BACKGROUND: Conventional MRI lesion measures modestly predict long term disability in some clinicall...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
In this study, the course of 60 consecutive multiple sclerosis patients (relapsing-remitting (RR), r...
The association of pathology and neurological deficit with quality of life (QoL) in multiple scleros...
Using serial magnetic resonance imaging (MRI), we investigated the relationship between diffuse cere...
OBJECTIVE: The objective of this paper is to identify clinical or magnetic resonance imaging (MR...
INTRODUCTION: T2-weighted and gadolinium enhanced T1-weighted MRI scans measure plaque burden and br...